SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Scienture Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.92−0.44 (-13.10%)
Close on Oct 19, 2026
- Market cap
- $115.68M
- P/E (TTM)
- –
- Dividend yield
- –
Scienture Holdings, Inc. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- 166.9%
- Operating margin
- -9284.1%
- Net margin
- -8793.2%
- Return on equity, FY2025
- -55.6%
Financial strength
- Current ratio
- 3.04
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 270.6%
Valuation
- P/E ratio
- –
- Price to sales
- 268.02
- Price to book
- 1.80
- Dividend yield
- –